Clinical Trial Update: A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Nirogacestat for desmoid tumors that are unresectable or recurrent, currently listed as active not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Desmoid Fibromatosis
• Desmoid Tumor

Drugs mentioned

• Nirogacestat (nirogacestat)

Snippet

Sponsor: Children's Oncology Group | Conditions: Desmoid Fibromatosis, Recurrent Desmoid Fibromatosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING